In a 75-year-old man with a red blood cell count of 3.76 ×10⁶/µL, hemoglobin 11.5 g/dL, and hematocrit 35.4%, what is the most likely diagnosis and appropriate treatment?

Diagnosis and Treatment of Anemia in a 75-Year-Old Male

This 75-year-old male has mild normocytic anemia (hemoglobin 11.5 g/dL, hematocrit 35.4%) that requires immediate diagnostic workup to identify the underlying cause before initiating treatment.

Diagnostic Classification

Anemia Confirmation

• Anemia is confirmed based on WHO criteria: hemoglobin < 13 g/dL in adult males 1
• The hematocrit of 35.4% correlates appropriately with hemoglobin 11.5 g/dL (ratio approximately 3:1) 2, 3
• This represents mild anemia (hemoglobin 10.0-12.9 g/dL in males) 1

Morphologic Classification

• With RBC count 3.76 × 10⁶/µL, the calculated MCV is approximately 94 fL (35.4 ÷ 3.76 = 94), indicating normocytic anemia 4, 5
• Normocytic anemia in elderly males suggests: acute hemorrhage, hemolysis, anemia of chronic inflammation, renal insufficiency, or bone marrow failure 4, 5

Critical Diagnostic Workup Required

Immediate Laboratory Tests Needed

• Reticulocyte count and reticulocyte index to distinguish decreased RBC production (RI < 2.0) from hemolysis/blood loss (RI > 2.0) 5
• Serum ferritin and transferrin saturation to assess iron stores (ferritin < 30 ng/mL diagnostic for iron deficiency) 1, 4
• Serum creatinine and estimated GFR to evaluate for chronic kidney disease, which causes anemia through decreased erythropoietin production 1, 5
• Vitamin B12 and folate levels to exclude nutritional deficiencies 1, 4
• Peripheral blood smear to identify hemolysis (schistocytes, spherocytes) or other morphologic abnormalities 5

Additional Evaluation Based on Clinical Context

• Stool guaiac test or fecal occult blood to detect gastrointestinal bleeding 1, 5
• Thyroid function tests if hypothyroidism suspected 4
• Liver function tests and inflammatory markers (CRP, ESR) to assess for chronic disease 1

Treatment Algorithm

If Reticulocyte Index < 2.0 (Decreased Production)

Iron Deficiency Anemia:

• First-line: Oral iron supplementation (ferrous sulfate 325 mg daily or every other day, as intermittent dosing shows equal efficacy with fewer side effects) 1, 6
• Second-line: Intravenous iron if oral iron not tolerated, not absorbed, or ineffective 1, 6

Vitamin B12/Folate Deficiency:

• Vitamin B12 deficiency: Cyanocobalamin 1000 mcg intramuscularly monthly for life if pernicious anemia; oral supplementation if dietary deficiency 7
• Critical warning: Never give folic acid alone without excluding B12 deficiency, as it may correct anemia while allowing irreversible neurologic damage to progress 7

Chronic Kidney Disease:

• Treat underlying renal disease as primary therapy 1, 5
• Consider erythropoiesis-stimulating agents only after correcting iron deficiency (functional iron deficiency defined as ferritin < 100 ng/mL or transferrin saturation < 20%) 5

Anemia of Chronic Disease:

• Address underlying inflammatory condition as primary therapy 1, 4

If Reticulocyte Index > 2.0 (Hemolysis or Blood Loss)

Hemolysis:

• Perform direct antiglobulin (Coombs) test, haptoglobin, indirect bilirubin, and LDH 1, 5
• Treat underlying cause (autoimmune hemolytic anemia, microangiopathic process)

Acute or Chronic Blood Loss:

• Identify and control bleeding source 5
• Endoscopy if gastrointestinal bleeding suspected 1
• Replace iron stores after bleeding controlled

Transfusion Decision

When to Transfuse

Do NOT base transfusion solely on hemoglobin threshold 1, 4, 5

Transfuse if:

• Symptomatic (dyspnea, chest pain, dizziness, fatigue limiting activities) regardless of hemoglobin level 1
• Asymptomatic with high-risk comorbidities (cardiovascular disease, pulmonary disease, cerebrovascular disease) 1
• Progressive decline in hemoglobin despite treatment 1

Observe if:

• Asymptomatic without significant comorbidities 1

Transfusion Specifics

• One unit of packed RBCs increases hemoglobin by approximately 1 g/dL 1
• Hemoglobin equilibrates within 15-30 minutes in normovolemic patients not actively bleeding 3
• Use minimum units necessary to relieve symptoms (restrictive strategy preferred for hemodynamically stable patients) 1

Critical Pitfalls to Avoid

• Do not assume anemia is normal aging in elderly males—it reflects underlying disease and increases mortality risk 1, 5
• Do not delay workup for chronic kidney disease, as anemia prevalence increases dramatically with declining GFR 1, 5
• Do not give folic acid empirically without excluding B12 deficiency first 7
• Do not transfuse based on arbitrary hemoglobin triggers—assess symptoms and comorbidities 1, 4
• Screen for gastrointestinal malignancy in elderly males with new-onset anemia, as occult bleeding is common 1